Johnson & Johnson applies to WHO for emergency use listing of its COVID-19 vaccine
By Kim in News
Updated 3 years ago
Johnson & Johnson said an emergency use listing is a prerequisite for supplying doses to the COVAX vaccine program
/cloudfront-us-east-1.images.arcpublishing.com/tgam/RVKVWNA77NJIFIT3WHVPJAJOXU.jpg)